radionuclid assess infarct size ventricular function clinic trial thrombolysi mortal ventricular eject fraction infarct size import end point effici thrombolyt treatment clinic trial radionuclid assess eject fraction infarct size safe accur reproduc avail use clinic trial supplement mortal data allow meaning result trial patient number singl photon emiss tomographi detect quantif infarct size use new radiopharmaceut import role futur trial period techniqu western washington thrombolysi trial infarct size eject fraction patient streptokinas tissue-typ plasminogen activ recent trial direct relat end point time symptom onset initi treatment futur trial effort treatment first hour symptom onset observ 